Maaisha Osman was the Spring 2023 editorial intern at Spectrum, writing articles about the latest in autism research. She graduated from the Northeastern Journalism School in Boston, Massachusetts, and was an editor at Storybench — a digital publication on media innovation. Her work has appeared in STAT, The Bay State Banner and other local news outlets in Boston. You can find her on Twitter @MaaishaO.
Maaisha Osman
Former news intern
Spectrum
From this contributor
Abundant motor proteins disrupt cries in FOXP2 mice
Knocking down the gene that codes for the proteins normalizes the vocalizations.
Abundant motor proteins disrupt cries in FOXP2 mice
Two scientists, two interventions: A ‘gentle rivalry’ to aid autistic children
Minimally verbal autistic preschoolers gained new words and phrases in a head-to-head comparison of two interventions.
Two scientists, two interventions: A ‘gentle rivalry’ to aid autistic children
Medicaid waivers curb disenrollment among autistic young adults
Autistic people tend to drop out of Medicaid once they reach adulthood in states that don’t waive the income restrictions on enrollment.
Medicaid waivers curb disenrollment among autistic young adults
Autism intervention before age 2 may aid social, language skills
Autistic toddlers who receive a personalized intervention at about 18 months of age gain more abilities than those who start the therapy nine months later.
Autism intervention before age 2 may aid social, language skills
Black and women researchers are less likely to hold three or more NIH grants simultaneously
A growing proportion of researchers has reached such “super principal investigator” status, but the distribution is not even across demographic groups.
Black and women researchers are less likely to hold three or more NIH grants simultaneously
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.